Global impact of pandemic by SARS-CoV-2 on breast cancer diagnosis and screening
DOI:
https://doi.org/10.29289/2594539420210057Palavras-chave:
coronavirus, early detection of cancer, neoplasms, SARS-CoV-2Resumo
ABSTRACT: Introduction: The pandemic related to the new coronavirus is characterized by high rates of contamination, transmissibility, and mortality. The measures of social isolation adopted by the World Health Organization and corroborated by several countries, with a view to avoiding or minimizing the transmission of COVID-19, can lead to the reduction of the capacity of screening and diagnosis of diseases, such as breast cancer. Objective: This study aimed to analyze the diagnostic indexes and mamaria malignancy diagnosis test, such as mammogram, during the COVID-19 pandemic period. Methodology: Systematic review of the literature based on studies found in the PubMed, SciELO, LILACS, and ScienceDirect databases. Results: The six selected articles demonstrate a reduction in the diagnosis of breast cancer during the pandemic, although with discordant rates. Outcomes such as reduced number of mammograms and change in tumor stage were also analyzed. Conclusion: It is essential to maintain care with the screening, diagnosis, and treatment of breast cancer, in order to minimize the damage caused over more than 1 year of COVID-19 pandemic.
Downloads
Referências
Vrdoljak E, Balja MP, Marušić Z, Avirović M, Blažičević V, Tomasović Č, et al. COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study. Oncologist. 2021;26(7):e1156-60. https://doi.org/10.1002/onco.13791
Eijkelboom AH, de Munck L, Lobbes MBI, van Gils CH, Wesseling J, Westenend PJ, et al. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic. Prev Med. 2021;151:106602. https://doi.org/10.1016/j.ypmed.2021.106602
Eijkelboom AH, de Munck L, Peeters MJTFDV, Broeders MJM, Strobbe LJA, Bos MEMM et al. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study. J Hematol Oncol.2021;14:64. https://doi.org/10.1186/s13045-021-01073-7
Peacock HM, Tambuyzer T, Verdoodt F, Calay F, Poirel HA, De Schutter H, et al. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis. ESMO Open. 2021;6(4):100197. https://doi.org/10.1016/j.esmoop.2021.100197
Toss A, Isca C, Venturelli M, Nasso C, Ficarra G, Bellelli V, et al. Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era. ESMO Open. 2021;6(2):100055. https://doi.org/10.1016/j.esmoop.2021.100055
Lôbo CC, Pinhiero LGP, Vasques PHD. Impact of the COVID-19 pandemic on breast cancer diagnosis. Mastology. 2020;30:1-5. https://doi.org/10.29289/25945394202020200059
Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening–viewpoint of the IARC Working Group. N Engl J Med. 2015;372(24):2353-8. https://doi.org/10.1056/NEJMsr1504363
Zadnik V, Mihor A, Tomsic S, Zagar T, Bric N, Lokar K, et al. Impact of COVID-19 on cancer diagnosis and management in Slovenia – preliminary results. Radiol Oncol. 2020;54(3):329-34. https://doi.org/10.2478/raon-2020-0048
Chen RC, Haynes K, Du S, Barron J, Katz AJ. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 2021;7(6):878-84. https://doi.org/10.1001/jamaoncol.2021.0884
Sharpless NE. COVID-19 and cancer. Science. 2020;368(6497):1290. https://doi.org/10.1126/science.abd3377
Nyante SJ, Benefield TS, Kuzmiak CM, Earnhardt K, Pritchard M, Henderson LM. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures. Cancer. 2021;127(12):2111-21. https://doi.org/10.1002/cncr.33460
Bessa JF. Breast imaging hindered during Covid-19 pandemic, in Brazil. Rev Saúde Publica. 2021;55:1-8. https://doi.org/10.11606/s1518-8787.2021055003375
Instituto Nacional de Câncer. Estatísticas de câncer. Instituto Nacional de Câncer, Ministério da Saúde; 2020. [cited on Set. 08, 2021]. Available from: https://www.inca.gov.br/numeros-de-cancer
Collado-Mesa F, Kaplan SS, Yepes MM, Thurber MJ, Behjatnia B, Kallos NPL. Impact of COVID-19 on breast imaging case volumes in South Florida: a multicenter study. Breast J. 2020;26(11):2316-9. https://doi.org/10.1111/tbj.14011
Miller MM, Meneveau MO, Rochman CM, Schroen AT, Lattimore CM, Gaspard PA, et al. Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors. Breast Cancer Res Treat. 2021;189(1):237-46. https://doi.org/10.1007/s10549-021-06252-1
Song H, Bergman A, Chen AT, Ellis D, David G, Friedman AB, et al. Disruptions in preventive care: mammograms during the COVID-19 pandemic. Health Serv Res. 2021;56(1):95-101. https://doi.org/10.1111/1475-6773.13596
Yong JH, Mainprize JG, Yaffe MJ, Ruan Y, Poirier AE, Coldman A, et al. The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada. J Med Screen. 2021;28(2):100-7. https://doi.org/10.1177/0969141320974711
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2026 Amanda Dezordi Dall’Agnol, Ana Katharina Dalbosco, Giordana Vitória Bertozzo Suzin, Mauricio Both, Valentina Antonio Simonetti, Emily Sanini Guimarães, Luciano Luiz Alt, Lia Mara Wibelinger
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
